Organisation paid for research Program year 2022 Source: CMS Open Payments

WR Clinsearch

Neither a doctor nor a teaching hospital

Research payments

$226,607

6 payments

Through program year 2022, WR Clinsearch is reported as receiving $226,607 in research payments, across 6 payments.

By program year

4 rows

Year	Kind	Amount	Payments
2022	Research	$55,473	2
2021	Research	$20,169	2
2020	Research	$77,132	1
2019	Research	$73,833	1

Breakdown

Who paid Research payments · program years 2019–2022

Novartis Pharmaceuticals Corporation $155,921 3 payments
Merck Sharp & Dohme Corporation $70,686 3 payments

Studies the money was for Research payments · program years 2019–2022

A Randomized Double Blind Multicenter Study to Assess the Safety Tolerability and Efficacy of A Combination Treatment of Tropifexor Ljn452 and Cenicriviroc CVC in Adult Patients With Nonalcoholic Steatohepatitis Nash and Liver Fibrosis $155,921 3 payments
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age $70,686 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.